Atia Vision: Funding, Investors & Team (Sep 2026)
Atia Medical is a medical device company focusing on advancing eye care through the innovation of ophthalmic devices, diagnostics, and pharmaceuticals. The company is focused on developing advanced solutions that get to market faster, reduce risk, increase impact, and forge a path toward a world where all people are able to lead longer healthier lives. They improving patient outcomes through the development of a modular presbyopia-correcting accommodating intraocular lens. Atia Vision modular intraocular lens technology features an accommodating base responsive to the ciliary muscles, simulating the natural mechanism of the eye and fixed lens element that allows for subsequent refractive correction. The company's unique technology enables natural accommodation, utilizing the ciliary muscles of the eye and providing for subsequent refractive correction, to restore the full range of functional vision for cataract patients. Atria Vision was founded in 2012 and is headquartered in Campbell, California, United States.
Atia Vision has raised $28.7M across 1 funding round on record, the most recent an undisclosed round of $28.7M announced in Aug 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Atia Vision Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Atia Vision Funding Rounds
Atia Vision Founders and Leadership Team
No contact details are on record for this team yet.
Atia Vision Funding Compared to Other Biotechnology Startups
Atia Vision's latest round of $28.7M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Atia Vision in Biotechnology and Campbell
Companies Similar to Atia Vision
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Atia Vision Funding FAQs
What does Atia Vision do?
Atia Medical is a medical device company focusing on advancing eye care through the innovation of ophthalmic devices, diagnostics, and pharmaceuticals. The company is focused on developing advanced solutions that get to market faster, reduce risk, increase impact, and forge a path toward a world where all people are able to lead longer healthier lives. They improving patient outcomes through the development of a modular presbyopia-correcting accommodating intraocular lens. Atia Vision modular intraocular lens technology features an accommodating base responsive to the ciliary muscles, simulating the natural mechanism of the eye and fixed lens element that allows for subsequent refractive correction. The company's unique technology enables natural accommodation, utilizing the ciliary muscles of the eye and providing for subsequent refractive correction, to restore the full range of functional vision for cataract patients. Atria Vision was founded in 2012 and is headquartered in Campbell, California, United States.
How much funding has Atia Vision raised?
Atia Vision has raised $28.7M across 1 round on record. The most recent is an undisclosed round of $28.7M announced in Aug 2022.
When did Atia Vision last raise funding?
Atia Vision's most recent funding round on record is an undisclosed round of $28.7M, announced in Aug 2022.
Who founded Atia Vision?
FundedIQ lists Claudio Argento (Founder) at Atia Vision.
Where is Atia Vision headquartered?
Atia Vision is based in Campbell, California, United States.
How many employees does Atia Vision have?
Atia Vision is in the 11-50 employee band.
How does Atia Vision's funding compare to other Biotechnology startups?
Atia Vision's latest round of $28.7M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Atia Vision Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Atia Vision is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.